Pan Medical UK, based in the South West, has received US Food and Drug Administration (FDA) approval for the repair of spinal compression fractures with its Kyphoplasty range of products.
A Kyphoplasty surgical procedure is designed to stop the pain caused by a spinal fracture through stabilising the bone and restoring some or all of the lost vertebral body height due to the compression fracture. These are commonly caused by thinning of the bones, osteoporosis, cancer or injury.
Pan Medical invested over four years of development for its Kyphoplasty products which are manufactured in the United Kingdom, ensuring commitment to quality with each balloon individually tested to 30atm. Further innovation and development led to the InterV Mini, which has a lower profile and is less traumatic providing wider use options, and the InterV-X which is specifically designed for the fixation of traumatic compression fractures.
Dr. Max Nasralla, Managing Director says; "This is an exciting time for Pan Medical; we are looking forward to conquering the American Kyphoplasty market with our innovative, high quality products."
As a result of expanding in to the US market, Pan Medical are opening brand new offices in Tampa, Florida with the official launch in June 2014.
